Content: cookies-message

We use first and third party cookies to enable the browsing through the website and to improve the services by analyzing your browsing habits. If you continue browsing the website, you accept its installation and use as aforementioned. You may modify the settings and obtain more information here

  • Investors
    • Investors
    • Financials
      • Quarterly reports
      • Annual accounts
      • CNMV communications
      • SEC communications
      • Fixed income and credit ratings
      • Average period of payment to suppliers
    • Stock information
      • Stock and share capital
      • Dividends
      • Agreements between shareholders
      • Major holders and treasury stock
    • Corporate governance
      • Board of Directors
      • Shareholders’ general meeting
      • Annual corporate governance report
      • Directors' remuneration report
      • Corporate responsibility report
      • Articles of association
      • Corporate policies
    • Press releases
    • Presentations
    • Relevant events
    • Agenda
  • Careers
    • Careers
  • Media
    • Media
    • Media contacts
    • Newsroom
  • Contact
    • Contact
    • International Headquarters
    • Adverse reactions – Pharmacovigilance
  • English
    • English
    • Spanish
  • Company
    • Company
    • Mission
    • Our values
    • History
    • Divisions
      • Bioscience
      • Diagnostic
      • Hospital
      • Bio Supplies

    Content: company-destacado-1

    Grifols

    We improve the health and well-being of patients around the world.

    Read more

    Content: company-destacado-2

    Grifols

    Four business divisions united by a shared commitment to quality, safety and on-going innovation.

    Read more
  • Commitment
    • Commitment
    • Commitment to patients
    • Commitment to science
    • Foundations
    • The environment
    • Ethics and compliance

    Content: commitment-destacado-1

    Grifols

    Patients inspire the work we do every day.

    Read more

    Content: commitment-destacado-2

    Grifols

    We support the development of the scientific community and its research efforts.

    Read more
  • Innovation
    • Innovation
    • Research areas
    • Project pipeline
    • AMBAR
      • Alzheimer's disease
      • Grifols and Alzheimer’s
      • The AMBAR hypothesis
      • The AMBAR study
      • The results

    Content: innovation-destacado-1

    Grifols

    Take a look at the portfolio of products and therapies currently in development.

    Read more

    Content: innovation-destacado-2

    Grifols

    AMBAR, an ambitious research project on Alzheimer's.

    Read more
  • Team
    • Team
    • Grifols culture
    • Global footprint
    • Training and development

    Content: team-destacado-1

    Grifols

    We strive to cultivate a friendly, diverse and inclusive work environment.

    Read more

    Content: team-destacado-2

    Grifols

    Grifols is becoming increasingly global. A diverse team will remain a key component to our future success.

    Read more
  • Products and services
  • Company
    • Company
    • Mission
    • Our values
    • History
    • Divisions
      • Bioscience
      • Diagnostic
      • Hospital
      • Bio Supplies
  • Commitment
    • Commitment
    • Commitment to patients
    • Commitment to science
    • Foundations
    • The environment
    • Ethics and compliance
  • Innovation
    • Innovation
    • Research areas
    • Project pipeline
    • AMBAR
      • Alzheimer's disease
      • Grifols and Alzheimer’s
      • The AMBAR hypothesis
      • The AMBAR study
      • The results
  • Team
    • Team
    • Grifols culture
    • Global footprint
    • Training and development
  • Products and services
  • Investors
    • Investors
    • Financials
      • Quarterly reports
      • Annual accounts
      • CNMV communications
      • SEC communications
      • Fixed income and credit ratings
      • Average period of payment to suppliers
    • Stock information
      • Stock and share capital
      • Dividends
      • Agreements between shareholders
      • Major holders and treasury stock
    • Corporate governance
      • Board of Directors
      • Shareholders’ general meeting
      • Annual corporate governance report
      • Directors' remuneration report
      • Corporate responsibility report
      • Articles of association
      • Corporate policies
    • Press releases
    • Presentations
    • Relevant events
    • Agenda
  • Careers
    • Careers
  • Media
    • Media
    • Media contacts
    • Newsroom
  • Contact
    • Contact
    • International Headquarters
    • Adverse reactions – Pharmacovigilance
English
  • English
  • Spanish

Content: grifols-alert-popup

Discover our new corporate site

Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.

×

Content: footer-organization-info

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed to, promoting any products in countries in which they are not approved.

Content: footer-content-logos

Follow
© 2019 Grifols, S.A. All rights reserved worldwide.

Content: footer-content-links-1

ABOUT US

Company

Commitment

Innovation

Team

Products & services

Investors

Careers

Media

Content: footer-content-links-2

TOP WEBSITES

Grifols Plasma

Grifols Academy

Grifols Scientific Awards

Grifols Engineering

Fundación Grifols

Fundación Probitas

Content: footer-content-links-3-sense-site-map

HELP

Grifols group data Protection Policies

Privacy policy

Cookies policy

Terms of use

Contact

Content: footer-content-logos

Follow
© 2019 Grifols, S.A. All rights reserved worldwide.

This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?